Showing 1 - 10 of 20
Persistent link: https://www.econbiz.de/10010421600
Persistent link: https://www.econbiz.de/10012663313
Do stronger intellectual property rights incentivize female participation in innovation? We provide new evidence on this question using a unique database of artificial intelligence patents publicly shared by the USPTO. Our identification strategy leverages China's WTO TRIPs accession, which led...
Persistent link: https://www.econbiz.de/10014576575
Persistent link: https://www.econbiz.de/10014229272
Over the last decade, generic penetration in the U.S. pharmaceutical market has increased substantially, providing significant gains in consumer surplus. What impact has this rise in generic penetration had on the rate and direction of early stage pharmaceutical innovation? We explore this...
Persistent link: https://www.econbiz.de/10013032342
Even though management consultants increasingly recommend that in-house research be outsourced, little is known about the conditions favoring substitution or complementarity between internal R&D and external technology acquisition. In this paper, we attempt to provide a deeper understanding of...
Persistent link: https://www.econbiz.de/10014178802
Even though management consultants increasingly recommend that in-house research be outsourced, little is known about the conditions favoring substitution or complementarity between internal R&D and external technology acquisition. In this paper, we attempt to provide a deeper understanding of...
Persistent link: https://www.econbiz.de/10013064588
Persistent link: https://www.econbiz.de/10009722826
"One of the key issues the world grappled with during Covid-19 was the distributional implications of lockdowns globally. The shadow of lockdown policies continues when nations still try to emerge out of the pandemic. Heterogeneity herein over time, country and even within nations in policy...
Persistent link: https://www.econbiz.de/10013441761
Over the last decade, generic penetration in the U.S. pharmaceutical market has increased substantially, providing significant gains in consumer surplus. What impact has this rise in generic penetration had on the rate and direction of early stage pharmaceutical innovation? We explore this...
Persistent link: https://www.econbiz.de/10012458133